NIH Discharges Patient Exposed to Ebola
UPDATED Dec. 20 -The NIH Clinical Center has discharged the patient who was admitted to the hospital on December 11 following a high-risk exposure to Ebola virus while providing bedside nursing care in Sierra Leone.
According to a statement issued by NIH, the patient showed no clinical or laboratory evidence of Ebola infection and will complete 21 days of monitoring at a private residence in Virginia under the direction of the Virginia Department of Health.
“The patient feels well and has no fever,” the statement read. According to NIH, CDC guidelines pertaining to monitoring and isolation will be followed until the completion of the 21-day observation period from the time of reported exposure.
Dec. 11–The National Institutes of Health has admitted a patient with exposure to the Ebola virus to the NIH Clinical Center’s special clinical studies unit for observation and to enroll in a clinical protocol. According to a statement released by NIH, the patient is an American nurse who was volunteering services in an Ebola treatment unit in Sierra Leone.
According to NIH, the patient was transferred from an overseas location via private charter medevac in isolation and admitted to the NIH Clinical Center at approximately 12:42 p.m. on Dec. 11.
No additional details about the patient have been released.
NIH officials want the public to know that the special clinical studies unit is specifically designed to provide high-level isolation capabilities and is staffed by infectious diseases and critical care specialists. The unit staff is trained in strict infection control practices optimized to prevent spread of potentially transmissible agents such as Ebola. In addition, access to the unit is strictly controlled.
According to a statement issued by NIH, officials are taking every precaution to ensure the safety of patients, NIH staff, and the public. This situation presents minimal risk to any of them, according to NIH.
You can find more information about NIH’s clinical protocols online here.
The county’s health officer updated the Montgomery County Council Tuesday on the topics of Ebola, tuberculosis and school vaccinations. Dr. Ulder Tillman gives a public health briefing to the county council about twice a year. Of the 11,001 Montgomery County Public Schools’ sixth graders entering seventh grade in August, 7,098 still do not have the required Tdap (tetanus-diphtheria-acellular […]
UPDATED April 9, 5:44 p.m. The American healthcare worker admitted to the NIH Clinical Center on March 13 with the Ebola virus was discharged today in good condition after having been successfully treated at the NIH Clinical Center Special Clinical Studies Unit. According to NIH officials, the individual is no longer contagious to the community. No […]
Here are your five things to know today, April 8, in Montgomery County: 1. A Hate Crime: Gaithersburg police are looking for the vandal(s) who defaced a synagogue in the Lakelands community and city leaders are speaking out about the incident. 2. Getting Better: NIH officials have upgraded the condition of a patient with the Ebola […]
Here are your five things to know today, March 13, in Montgomery County. 1. The 41st annual Public Safety Awards ceremony takes place today at the Bethesda North Marriott. 2. A healthcare worker diagnosed with the Ebola virus is scheduled to be admitted to NIH today. 3. Meet the two MCPS students who are campaigning […]
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco said as the newly approved rapid diagnostic test for Ebola hits the market he will need to ramp up production at his startup company. Related:
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco said the approval of a rapid diagnostic test for Ebola is a gamechanger. Related:
In this MyMCMedia Extra video, Dr. Luis Branco said he plans to return to Eastern Sierra Leone sometime this year to continue work on the recently approved rapid diagnostic test for the Ebola virus. Despite progress, he said there are always more questions to answer. Related:
In this MyMCMedia Extra video, Zalgen Labs’ co-founder Dr. Luis Branco talks about his work on the rapid diagnostic test for Ebola late last year in Africa and what happened when he returned to the United States. The World Health Organization approved a rapid diagnostic test for Ebola last week. Related:
It’s called a gamechanger: a rapid diagnostic test for Ebola has recently been approved and a startup Germantown company, Zalgen Labs, played a part in the development of that test. MyMCMedia’s Sonya Burke reports. You can find more information about this development and the Viral Hemorrhagic Fever Consortium that made it happen on its website. […]
Susan Prince, development specialist for the Montgomery County Department of Economic Development, talks about Zalgen Labs and the impact that company’s success has on the life sciences industry here.